Porton Pharma Solutions Ltd. (SHE:300363)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Small Molecule Api Business	3.09B	2.74B	3.47B	-	-
Small Molecule Api Business Growth	12.86%	-20.97%	-	-	-
Emerging Business	304.96M	242.56M	180.02M	-	-
Emerging Business Growth	25.73%	34.74%	-	-	-
Other Operations	22.98M	29.80M	20.72M	79.13M	15.75M
Other Operations Growth	-22.88%	43.81%	-73.82%	402.41%	-60.08%
Chemical Drug R&D and Production Services	-	-	-	6.96B	3.09B
Chemical Drug R&D and Production Services Growth	-	-	-	125.15%	52.01%
Total	3.42B	3.01B	3.67B	7.03B	3.11B
Total Growth	13.54%	-17.87%	-47.87%	126.55%	49.87%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	1.09B	783.42M	855.33M	712.63M	679.03M
China Growth	38.68%	-8.41%	20.02%	4.95%	109.94%
Overseas	2.33B	2.23B	2.81B	6.32B	2.43B
Overseas Growth	4.70%	-20.75%	-55.52%	160.59%	38.76%
Total	3.42B	3.01B	3.67B	7.03B	3.11B
Total Growth	13.54%	-17.87%	-47.87%	126.55%	49.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error